cervical internal carotid artery stenosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients must meet all of the following inclusion criteria 1. Asymptomatic patients with cervical internal carotid artery stenosis of 40 to 79% stenosis 2. Patients who do not achieve the LDL-C target value on the guidelines, despite taking statin with the maximum tolerated dose approved in Japan for more than 3 months
Exclusion criteria
Exclusion criteria: Patients who meet any of the following exclusion criteria 1. Patients with symptomatic cervical internal carotid artery stenosis 2. Patients with serious renal impairment 3. Patients with hepatic dysfunction 4. MRI incompatible patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Signal change rate from baseline of carotid plaque on MRI-VISTA at 1 month, 2 months, 3 months, 6 months after the start of intense LDL-C lowering therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Parameter change of carotid plaque by carotid ultrasound | — |
Countries
Japan
Contacts
Hyogo Brain and Heart Center at Himeji Department of General Affairs